VivoSeq
Other

Islet Transplantation

0

Pipeline Programs

11

Active Trials

0

Companies Involved

Islet Transplantation is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

81/100

Attrition Rate

12/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

41

clinical trials

Completed22 · 54%
Recruiting5 · 12%
Terminated4 · 10%
Active, not recruiting3 · 7%
Not yet recruiting2 · 5%
Withdrawn1 · 2%
Other4 · 10%

Trial Activity

41 trials

Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
Recruiting··Phase 1/2·NCT02846571·2 enrolled
Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes
Recruiting··Phase 1/2·NCT03746769·20 enrolled
Adrenergic System in Islet Transplantation
Active, not recruiting·UUniversity of Pennsylvania·Phase 1·NCT03079921·11 enrolled
SGLT2i Therapy in Islet Transplantation (SIT)
Not yet recruiting·UUniversity of Minnesota·Phase 4·NCT07228195·40 enrolled
Autologous Islet Transplantation for Diabetes
Enrolling by invitation·SShanghai Zhongshan Hospital·Phase 1·NCT07118475·24 enrolled
Islet Transplantation Using Abatacept
Completed·EEmory University·Phase 2·NCT00276250·5 enrolled
Pancreatic Islet Transplantation Into the Gastric Submucosa
Completed··Phase 1·NCT01571817·1 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)